scholarly article | Q13442814 |
P356 | DOI | 10.1053/J.GASTRO.2004.10.002 |
P698 | PubMed publication ID | 15633129 |
P50 | author | Domenico Alvaro | Q54325183 |
P2093 | author name string | Yoshiyuki Ueno | |
Tania Roskams | |||
Gianfranco Alpini | |||
Shannon Glaser | |||
Antonio Benedetti | |||
Marco Marzioni | |||
Silvia Taffetani | |||
Giammarco Fava | |||
Heather Francis | |||
Gene D Lesage | |||
Jo Lynne Phinizy | |||
Juliet Venter | |||
Luca Marucci | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | serotonin | Q167934 |
P304 | page(s) | 121-137 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Gastroenterology | Q4039279 |
P1476 | title | Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin | |
P478 | volume | 128 |
Q52572352 | A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction. |
Q28569215 | A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis |
Q46843868 | Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. |
Q33627153 | Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. |
Q37175512 | Autocrine regulation of biliary pathology by activated cholangiocytes |
Q47986302 | Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice |
Q36919731 | Biogenic amine actions on cholangiocyte function |
Q34992316 | Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growth |
Q38194699 | Calcium signaling and the secretory activity of bile duct epithelia |
Q36506468 | Calcium signaling in cholangiocytes |
Q35601290 | Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone |
Q57128724 | Cellular crosstalk during cholestatic liver injury |
Q37175438 | Cholangiocyte proliferation and liver fibrosis. |
Q37067699 | Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides |
Q37975904 | Development of the bile ducts: essentials for the clinical hepatologist |
Q34272411 | Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats |
Q41503491 | Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis |
Q43185341 | Experimental obstructive cholestasis: the wound-like inflammatory liver response |
Q36792149 | Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure |
Q37264501 | Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1 |
Q34779022 | Functional anatomy of normal bile ducts |
Q35933236 | Functional and structural features of cholangiocytes in health and disease |
Q35236464 | Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms |
Q33866793 | Heterogeneity of the intrahepatic biliary epithelium |
Q38196813 | Histamine and histamine receptor regulation of gastrointestinal cancers |
Q39926096 | Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. |
Q34849635 | Identification of HSP90 as potential biomarker of biliary atresia using two-dimensional electrophoresis and mass spectrometry |
Q42467990 | Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents |
Q38280635 | Inhibition of the liver expression of arylalkylamine N-acetyltransferase increases the expression of angiogenic factors in cholangiocytes |
Q41878331 | Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury |
Q35475673 | Intraluminal volume homeostasis: A common sertonergic mechanism among diverse epithelia |
Q48223400 | Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling |
Q57369532 | Knockout of α-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice |
Q47813887 | Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats |
Q92174629 | Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis |
Q36592748 | Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes in rats |
Q64115037 | Molecular Evolution of Tryptophan Hydroxylases in Vertebrates: A Comparative Genomic Survey |
Q27355464 | Multiple cellular responses to serotonin contribute to epithelial homeostasis |
Q33866778 | Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis |
Q89761775 | Neuroendocrine Changes in Cholangiocarcinoma Growth |
Q37093626 | Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms. |
Q34597703 | Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. |
Q39440062 | Pathobiology of biliary epithelia. |
Q34623557 | Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches |
Q34347580 | Principles of liver regeneration and growth homeostasis |
Q36807790 | Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms |
Q28582467 | Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms |
Q41351001 | Prolonged administration of secretin to normal rats increases biliary proliferation and secretin-induced ductal secretory activity |
Q34439817 | Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis. |
Q37662251 | Recent advances in the morphological and functional heterogeneity of the biliary epithelium |
Q34358007 | Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology |
Q34755613 | Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases |
Q33863341 | Regulators of Cholangiocyte Proliferation |
Q34276575 | Role of cholangiocytes in primary biliary cirrhosis |
Q36996185 | Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth |
Q24297176 | Serotonin promotes tumor growth in human hepatocellular cancer |
Q38691065 | Simple resection of the lesion bile duct branch for treatment of regional hepatic bile duct stones |
Q35939397 | Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat. |
Q34487150 | Switching-on of serotonergic calcium signaling in activated hepatic stellate cells. |
Q37681599 | The Role of Serotonin Transporter in Human Lung Development and in Neonatal Lung Disorders. |
Q42515925 | The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. |
Q54976907 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. |
Q37898185 | The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view |
Q37149500 | Wound healing and local neuroendocrine regulation in the injured liver. |
Search more.